MeiraGTx Holdings (MGTX) Operating Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) reported Operating Margin of 35.13% for Q4 2025, up 18234.0% on a YoY basis from N/an in Q4 2024, and up 100.31% quarter-over-quarter from 11231.95% in Q3 2025.
MeiraGTx Holdings (MGTX) Operating Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Operating Margin for 7 years, with the latest figure at 35.13% in Q4 2025.
- For the quarter ending Q4 2025, Operating Margin rose 18234.0% year-over-year to 35.13%; the trailing twelve-month figure through Dec 2025 stood at 105.07% (up 38837.0% YoY), and the FY2025 full-year result was 130.2%, up 36324.0% from the prior year.
- Operating Margin for Q4 2025 stood at 35.13%, up from 11231.95% in the prior quarter.
- The five-year high for Operating Margin was 776.38% in Q4 2022, with the low at 16279.79% in Q2 2024.
- Historically, Operating Margin has averaged 2217.71% across 5 years, with a median of 479.48% in 2021.
- Annual changes were most pronounced in 2024 — Operating Margin plunged 1546665 bps — and 2025, when it jumped 1506621 bps.
- MeiraGTx Holdings' Operating Margin stood at 36.54% in 2021, then jumped by 2224 bps to 776.38% in 2022, then tumbled by 376 bps to 2144.8% in 2023, then surged by 93 bps to 147.22% in 2024, then soared by 124 bps to 35.13% in 2025.
- The last three Operating Margin figures came in at 35.13% (Q4 2025), 11231.95% (Q3 2025), and 1213.57% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 35.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.13% |
| Sep 30, 2025 | -11,231.95% |
| Jun 30, 2025 | -1,213.57% |
| Dec 31, 2024 | -147.22% |
| Sep 30, 2024 | -367.01% |
| Jun 30, 2024 | -16,279.79% |
| Mar 31, 2024 | -6,710.47% |
| Dec 31, 2023 | -2,144.80% |
| Sep 30, 2023 | -642.01% |
| Jun 30, 2023 | -813.14% |
| Mar 31, 2023 | -952.61% |
| Dec 31, 2022 | 776.38% |
| Sep 30, 2022 | -473.59% |
| Jun 30, 2022 | -220.82% |
| Mar 31, 2022 | -510.10% |
| Dec 31, 2021 | -36.54% |
| Sep 30, 2021 | -324.58% |
| Jun 30, 2021 | -400.37% |
| Mar 31, 2021 | -479.48% |
| Dec 31, 2020 | -348.94% |